Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Understanding the Clinical and Demographic Characteristics of Second Coronavirus Spike in 192 Patients in Tehran, Iran: A Retrospective Study Publisher



Arani HZ1 ; Manshadi GD2 ; Atashi HA1 ; Nejad AR3 ; Ghoranii SM1 ; Abolghasemi S4 ; Bahrani M5 ; Khaledian H1 ; Savodji PB1 ; Hoseinian M1 ; Bejandi AK1 ; Abolghasemi S4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Young Researchers and Elite Club, Islamic Azad University, Tehran Medical Sciences, Tehran, Iran
  2. 2. Department of Anesthesiology and Critical Care, Islamic Azad University, Tehran Medical Sciences, Tehran, Iran
  3. 3. Stem Cell and Regenerative Medicine Center of Excellence, Tehran Medical Sciences, Tehran, Iran
  4. 4. Department of Infectious Diseases, Islamic Azad University, Tehran Medical Sciences, Tehran, Iran
  5. 5. Department of Emergency Medicine, Faculty of Medicine, Islamic Azad University, Tehran Medical Sciences, Tehran, Iran
  6. 6. Islamic Azad University, Tehran Medical Sciences, Tehran, Iran

Source: PLoS ONE Published:2021


Abstract

During the last months of the coronavirus pandemic, with all those public restrictions and health interventions, the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appears now to have been raised in some countries around the world. Iran was one of those first countries facing the second wave of coronavirus, due to the lack of appropriate public restrictions because of economic problems the country is facing. The clinical and demographic characteristics of severe cases and non-severe cases of Coronavirus Disease (COVID-19) in 192 patients in Tehran, Iran, between June 16 and July 11, 2020, were investigated. The patients were divided into severe cases (n = 82) and non-severe cases (n = 110). Demographic and clinical characteristics were compared between the two study clusters. The mean age was 54.6 ± 17.2 years, and the most common presenting symptom was persistent cough (81.8%) and fever (79.7%). The logistic regression model revealed that age, BMI, and affected family members were statistically associated with severity. Patients with complicated conditions of disorders faced more hospitalization days and medical care than the average statistical data. As the coronavirus spike in the case and death reports from June 2020, we observed the rise in the incidence of severe cases, where 42.7% (82/192) of cases have resulted in severe conditions. Our findings also suggested that the effect of IFB (Betamethasone) was more valid than the other alternative drugs such as LPV/r and IVIg. © 2021 Public Library of Science. All rights reserved.
Other Related Docs
13. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
15. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)
19. Covid-19: Features, Clinical Course and Concerns, Journal of Cellular and Molecular Anesthesia (2020)
26. Potential Role of Interferons in Treating Covid-19 Patients, International Immunopharmacology (2021)
34. Critical Complications of Covid-19: A Descriptive Meta-Analysis Study, Reviews in Cardiovascular Medicine (2020)
44. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)